The United Laboratories International Holdings Limited (FRA:UNJ)
Germany · Delayed Price · Currency is EUR 1.250
0.00 (0.00%)
Last updated: Jan 30, 2026, 9:30 AM CET
FRA:UNJ Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 14,102 | 13,759 | 13,740 | 11,334 | 9,703 | 8,772 | |
Revenue Growth (YoY) | 0.66% | 0.14% | 21.22% | 16.81% | 10.61% | 4.53% |
Cost of Revenue | 7,440 | 7,677 | 7,405 | 6,365 | 5,492 | 4,966 |
Gross Profit | 6,662 | 6,082 | 6,335 | 4,969 | 4,211 | 3,806 |
Selling, General & Admin | 2,353 | 2,297 | 2,384 | 2,366 | 2,332 | 2,226 |
Research & Development | 942.9 | 890.76 | 757.25 | - | - | - |
Other Operating Expenses | -5.67 | 36.82 | 21.14 | 603.62 | 494.95 | 353.18 |
Operating Expenses | 3,309 | 3,263 | 3,168 | 2,954 | 2,829 | 2,576 |
Operating Income | 3,353 | 2,819 | 3,167 | 2,015 | 1,382 | 1,231 |
Interest Expense | -30.58 | -34.96 | -66.9 | -81.6 | -60.23 | -181.27 |
Interest & Investment Income | 135.66 | 127.79 | 105.42 | 70.74 | 82.78 | 112.79 |
Earnings From Equity Investments | 0.02 | -0.19 | 0.14 | -0.19 | - | - |
Currency Exchange Gain (Loss) | 52.15 | 117.82 | -2.95 | -21.68 | 42.67 | -30.32 |
Other Non Operating Income (Expenses) | 172.73 | 220.55 | 107.58 | 98.42 | -226.9 | -263.02 |
EBT Excluding Unusual Items | 3,683 | 3,250 | 3,310 | 2,081 | 1,220 | 868.81 |
Gain (Loss) on Sale of Investments | 111.85 | 66.5 | 72.75 | 17.97 | - | - |
Gain (Loss) on Sale of Assets | 3.73 | -4.27 | -3.7 | -4.39 | -3.3 | 43.54 |
Asset Writedown | 7.64 | -23.3 | -42.39 | -80.34 | -19.25 | 1.39 |
Other Unusual Items | 0.29 | -0.02 | 7.03 | -7.22 | 5.19 | -31.4 |
Pretax Income | 3,807 | 3,289 | 3,344 | 2,007 | 1,203 | 882.33 |
Income Tax Expense | 746.51 | 631.08 | 643.3 | 425.74 | 213.06 | 181.42 |
Earnings From Continuing Operations | 3,060 | 2,658 | 2,701 | 1,581 | 989.59 | 700.92 |
Minority Interest in Earnings | 2.28 | 1.88 | 0.51 | 0.07 | -1.49 | 2.07 |
Net Income | 3,063 | 2,660 | 2,701 | 1,581 | 988.1 | 702.99 |
Net Income to Common | 3,063 | 2,660 | 2,701 | 1,581 | 988.1 | 702.99 |
Net Income Growth | 5.31% | -1.54% | 70.85% | 60.01% | 40.56% | 9.54% |
Shares Outstanding (Basic) | 1,817 | 1,817 | 1,817 | 1,820 | 1,840 | 1,766 |
Shares Outstanding (Diluted) | 1,817 | 1,817 | 1,817 | 1,820 | 1,840 | 1,766 |
Shares Change (YoY) | -0.01% | -0.01% | -0.15% | -1.10% | 4.20% | 7.70% |
EPS (Basic) | 1.69 | 1.46 | 1.49 | 0.87 | 0.54 | 0.40 |
EPS (Diluted) | 1.69 | 1.46 | 1.49 | 0.87 | 0.54 | 0.40 |
EPS Growth | 5.32% | -1.53% | 71.11% | 61.80% | 34.90% | 1.71% |
Free Cash Flow | 734.42 | 1,484 | 1,165 | 1,251 | 1,060 | 1,037 |
Free Cash Flow Per Share | 0.40 | 0.82 | 0.64 | 0.69 | 0.58 | 0.59 |
Dividend Per Share | 0.440 | 0.440 | 0.400 | 0.190 | 0.120 | 0.080 |
Dividend Growth | - | 10.00% | 110.53% | 58.33% | 50.00% | 14.29% |
Gross Margin | 47.24% | 44.21% | 46.11% | 43.84% | 43.40% | 43.39% |
Operating Margin | 23.78% | 20.49% | 23.05% | 17.78% | 14.24% | 14.03% |
Profit Margin | 21.72% | 19.33% | 19.66% | 13.95% | 10.18% | 8.01% |
Free Cash Flow Margin | 5.21% | 10.79% | 8.48% | 11.04% | 10.93% | 11.82% |
EBITDA | 3,941 | 3,401 | 3,705 | 2,539 | 1,978 | 1,827 |
EBITDA Margin | 27.95% | 24.71% | 26.97% | 22.40% | 20.38% | 20.83% |
D&A For EBITDA | 587.73 | 581.59 | 538.01 | 523.67 | 596.06 | 596.36 |
EBIT | 3,353 | 2,819 | 3,167 | 2,015 | 1,382 | 1,231 |
EBIT Margin | 23.78% | 20.49% | 23.05% | 17.78% | 14.24% | 14.03% |
Effective Tax Rate | 19.61% | 19.19% | 19.24% | 21.21% | 17.72% | 20.56% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.